Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding Study of Wakix (Pitolisant) in OSA Patients with EDS
NCT01620554Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pitolisant in obstructive sleep apnea (OSA), sponsored by Bioprojet. Started Oct 2010; status: completed.
02
Drugs
pitolisant
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01620554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620554.